A younger epigenetic-age score can look like proof that an intervention is working. A major new analysis shows which clocks detect change—and why movement is not yet the same as longer healthspan.
Editorial Picks
Trending News
Based on last 48h engagement
Growth Hormone Receptor Deletion Extends Mouse Lifespan
International Longevity Summit Madrid 2026
A binding-to-release strategy for targeted anticancer drug delivery - Nature
Rewiring the ribosome to translate proteins encoded in its own RNA - Nature
Late-life semaglutide treatment slows ageing and extends lifespan in female mice - NatureUpcoming Events
View calendar
9. SEPT 2026 - 11. SEPT 202675th Annual Scientific Meeting of the BSRA: The Biology of Ageing
11. SEPT 2026 - 12. SEPT 2026ReGen Congress 2026
11. SEPT 2026 - 13. SEPT 2026Biohacking Congress Bad Dürrheim 2026
11. SEPT 2026 - 13. SEPT 2026Health Optimisation Summit London
28. SEPT 2026 - 1. OCT 2026International Longevity Summit Madrid 2026★
Reports preclinical evidence that a colon-targeted indole-3-acetic acid starch derivative preserves immune organ integrity and gut barrier function in chemotherapy-treated mice.
An AI-driven reverse‑engineering approach mines existing pharmacology and gene expression data to reveal additional disease targets for a late‑stage metabolic drug.
A paper develops and validates interpretable machine learning models to predict axillary web syndrome risk after breast cancer surgery, comparing algorithms and clinical predictors.
A short primer on a preclinical research article testing a small‑molecule adiponectin receptor agonist as a potential way to stimulate muscle growth and function in rodent models, useful for readers curious about emerging pharmacological strategies against muscle atrophy.
